Programmed death-ligand - Globe Thesis

Keyword [Programmed death-ligand] Result: 101 - 120 \| Page: 6 of 7
101.	Correlations Between The Expression Of PD-1/PD-L1 In Pulmonary Sarcomatoid Carcinoma And Its Clinical Characteristics
102.	Expression And Clinical Significance Of MSI And PD-L1 In HER2-positive Gastric Cancer
103.	The Expression And Clinical Significance Of Soluble Pd-l1in The Blood Plasma Of Patients With Hypopharyngeal Squamous Cell Carcinoma Receiving Radiotherapy
104.	The Effect Of IL-27 On The Expression Of Inflammatory Factors In Coronary Heart Disease Through JAK-STAT Signaling Pathway
105.	Expression And Clinical Significance Of PD-1/PD-L1 In Children With Acute Lymphoblastic Leukemia
106.	The Correlations Between HRCT Features And Pathological Classification And PD-L1 Expression In Lung Adenocarcinoma
107.	System Review And Clinical Pathology Evaluation Of PD-L1 As The Potential Biomarker In Breast Cancer
108.	Activating anti-tumor immunity by overcoming programmed death ligand 1-mediated immunosuppression
109.	Molecular Mechanism Of Regulation Of Macrophage Immunometabolism By Mesenchymal Stem Cells
110.	An Experimental Study On Treatment Of Liver Cancer By Sorafenib Loaded Prussian Blue Nanoparticles Combined With Anti-PD-L1 Monoclonal Antibody
111.	Predictive Value And Mechanism Of Programmed Death Ligand 1 In Neoadjuvant Therapy In Breast Cancer
112.	Expression And Function Identification Of PD-L1-pH Low Responsive Peptide Fusion Protein
113.	Initial Research On The Inhibition Of Postoperative Recurrence And Metastasis Of Triple Negative Breast Cancer With Durvalumab And PLGA-GEM Gel
114.	Study On The Role And Mechanism Of Programmed Death Ligand 1 In Surgical Brain Injury
115.	The Significance Of Combined Expression Of PD-L1,PARP1 And VEGF In Targeted Therapy Of Ovarian Clear Cell Carcinoma
116.	Correlation Between PD-L1 Expression In Tumor-associated Macrophages And Effect Of Neoadjuvant Chemotherapy In Bladder Cancer
117.	Analysis Of Differences In Immune Microenvironment Between Patients With EGFR Mutation And Wild-type NSCLC
118.	Clinical Characteristics And Related Analysis Of EGFR?ALK?ROS1 And PD-1/PD-L1 In Non-small Cell Lung Cancer
119.	Cisplatin Promotes PD-L1 Expression In A549 Human Lung Adenocarcinoma Cells Via Activating ERK Pathway
120.	A Correlation Study Of The Effect Of Autophagy On Gefitinib Sensitivity And PD-L1 In PC9/GR Cells
<<First <Prev Next> Last>> Jump to